A conservative report that reads well! My unlicenced advice to...

A conservative report that reads well! My unlicenced advice to most holders would be to read it carefully a few times prior to form judgement.

From the RM Research report get a clearer picture of the future CDY road map, pipeline time frames and overall positioning. Unlike many other biotechs with blue sky therapeutic pipelines, much of the funding here will clearly come from the (also blue sky) potential of the diagnostics.



cheers